The successful clinical application of immune checkpoint blockade (ICB) and chimeric
antigen receptor T cells (CAR-T) therapeutics has attracted extensive attention to …

Epstein-Barr virus (EBV) is typically found in a latent, asymptomatic state in
immunocompetent individuals. Perturbations of the host immune system can stimulate viral …

Abstract Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus,
which establishes permanent infection in humans. EBV causes infectious mononucleosis …

Epstein-Barr virus (EBV) is a global public health concern, as it is known to cause multiple
diseases while also being etiologically associated with a wide range of epithelial and …

Vaccination has saved billions of human lives and has considerably reduced the economic
burden associated with pandemic and endemic infectious diseases. Notwithstanding major …

Epstein‒Barr virus (EBV) is a double-stranded DNA virus belonging to the family
Orthoherpesviridae that is associated with the development of various tumors, such as …

Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90%
of the planet's adult population is infected. Symptomatic primary infection by this …

Pseudorabies virus (PRV) mainly causes pseudorabies (PR) or Aujeszky's disease in pigs
and can infect humans, raising public health concerns about zoonotic and interspecies …

Introduction Epstein-Barr virus (EBV) is an oncogenic human herpesvirus associated with~
350,000 cases of lymphoid and epithelial malignancies every year, and is etiologically …

This study aimed to investigate the protective effect of mini-hemagglutinin (mini-HA) proteins
expressed on lumazine synthase (LS) nanoparticles against influenza. Soluble mini-HA …